Pre- and post-conceptional tobacco effects on the CD-1 mouse fetus.
The objective of this study was to examine the effect of subchronic administration of an aqueous extract of smokeless tobacco (ST) on the development of the CD-1 mouse fetus. Mice were administered ST for approximately 5 weeks: for 2 weeks prior to breeding, during breeding, and during gestational days 0 to 17. Thus the initial peak nicotine levels occurred prior to breeding and not during the critical periods of gestation. Two ST dosages were administered by gastric intubation three times daily: ST/D-1, equivalent to a dose of 12 mg nicotine/kg of body weight, and ST/D-2, equivalent to 20 mg nicotine/kg body weight. Maternal plasma nicotine levels were determined 30 min after the second intubation during the pretreatment and gestational phases of treatment. At these ST dosages, the weight gain of ST-treated dams was not significantly affected in comparison to treated controls. The mean maternal plasma nicotine level for the low-dosage group was 363 ng/ml, and 481 ng/ml for the high-dosage group, with maternal lethality observed at 9.6% and 28.2%, respectively. No significant differences were seen between control and ST/D-1 maternal and/or fetal values, except for placental weights which were heaviest in the ST group (P less than 0.05). Several differences were noted between the ST/D-2 group and controls: fetal weights were reduced by 5.4% (P less than 0.05); decreased ossification was seen in femur measurements and in nine of ten characteristics measured (P less than 0.05); the frequency of resorptions (7.6%) was almost doubled (controls 4.2%); and the frequency of deaths and malformations was not affected. Under these experimental conditions, the low dose produced a negligible effect on the CD-1 mouse fetus and the dam. The high dose demonstrated growth retardation (P less than 0.05), increased embryotoxicity, and a significant decrease in ossification (P less than 0.05).
Paulson
R B
RB
Department of Oral Biology, College of Dentistry, Ohio State University, Columbus 43210.
Shanfeld
J
J
Prause
L
L
Iranpour
S
S
Paulson
J O
JO
D000014:Abnormalities, Drug-Induced; D000704:Analysis of Variance; D000818:Animals; D001835:Body Weight / Q000187:drug effects; D016009:Chi-Square Distribution; D003367:Cotinine / Q000097:blood; D005314:Embryonic and Fetal Development / Q000187:drug effects*; D005260:Female; D005306:Fertilization; D006801:Humans; D008297:Male; D051379:Mice; D009538:Nicotine / Q000097:blood; D010012:Osteogenesis / Q000187:drug effects; D008517:Phytotherapy; D010947:Plants, Toxic; D011247:Pregnancy; D013723:Teratogens; D014030:Tobacco, Smokeless / Q000008:administration & dosage / Q000633:toxicity*
D013723:Teratogens; D009538:Nicotine; D003367:Cotinine